Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02954809 · ClinicalTrials.gov registry record · NA
Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02954809 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 14 participants.
The verdict
NCT02954809, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
Interventions
- DEVICE Morning bright light therapy
- DEVICE Dim light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02954809
The ClinicalTrials.gov registry entry for NCT02954809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Morning bright light therapy is the first listed.
NCT02954809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02954809 about?
NCT02954809 is a clinical study titled "Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors". The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
What is the current status of trial NCT02954809?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-10. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02954809?
The interventions under investigation include: Morning bright light therapy (DEVICE), Dim light (DEVICE).
Who is sponsoring clinical trial NCT02954809?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.